Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Future Oncology (London, England)
|
April 2, 2020
Quality of life with second or third line <i>nab</i>-paclitaxel-based regimens in advanced non-small-cell lung cancer
Santiago Ponce Aix, Denis Talbot, Ramaswamy Govindan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 20, 2015
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis
Jia-Horng Kao, Donald M Jensen, Michael P Manns, et al.
Japanese Journal of Ophthalmology
|
December 26, 2025
Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trial
Kiyoshi Suzuma, Toshinori Murata, Masahiko Shimura, et al.
The New England Journal of Medicine
|
October 4, 2023
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper
Robert F Spiera, Sebastian Unizony, Kenneth J Warrington, et al.
Japanese Journal of Ophthalmology
|
December 26, 2025
Intravitreal aflibercept 8 mg in patients from Japan with neovascular age-related macular degeneration: 48-week subgroup analysis of the PULSAR trial
Hideki Koizumi, Shigeru Honda, Tsutomu Yasukawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2017
Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials
Dirk Schadendorf, Jedd D Wolchok, F Stephen Hodi, et al.
Open Forum Infectious Diseases
|
May 25, 2023
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial
Selin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, et al.
Clinical Lung Cancer
|
October 24, 2020
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial
David R Spigel, Robert M Jotte, Santiago Ponce Aix, et al.
Cancer
|
November 2, 2018
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC)
Daniel Morgensztern, Manuel Cobo, Santiago Ponce Aix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2017
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
Mario Sznol, Pier Francesco Ferrucci, David Hogg, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Future Oncology (London, England)
|
April 2, 2020
Quality of life with second or third line <i>nab</i>-paclitaxel-based regimens in advanced non-small-cell lung cancer
Santiago Ponce Aix, Denis Talbot, Ramaswamy Govindan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 20, 2015
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis
Jia-Horng Kao, Donald M Jensen, Michael P Manns, et al.
Japanese Journal of Ophthalmology
|
December 26, 2025
Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trial
Kiyoshi Suzuma, Toshinori Murata, Masahiko Shimura, et al.
The New England Journal of Medicine
|
October 4, 2023
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper
Robert F Spiera, Sebastian Unizony, Kenneth J Warrington, et al.
Japanese Journal of Ophthalmology
|
December 26, 2025
Intravitreal aflibercept 8 mg in patients from Japan with neovascular age-related macular degeneration: 48-week subgroup analysis of the PULSAR trial
Hideki Koizumi, Shigeru Honda, Tsutomu Yasukawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2017
Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials
Dirk Schadendorf, Jedd D Wolchok, F Stephen Hodi, et al.
Open Forum Infectious Diseases
|
May 25, 2023
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial
Selin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, et al.
Clinical Lung Cancer
|
October 24, 2020
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial
David R Spigel, Robert M Jotte, Santiago Ponce Aix, et al.
Cancer
|
November 2, 2018
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC)
Daniel Morgensztern, Manuel Cobo, Santiago Ponce Aix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2017
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
Mario Sznol, Pier Francesco Ferrucci, David Hogg, et al.
Page
of 6